Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users
- 12 July 2002
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 17 (6) , 309-312
- https://doi.org/10.1002/hup.415
Abstract
Rationale The recreational use of MDMA/Ecstasy (3,4‐methylenedioxymethamphetamine) is associated with many psychobiological problems, but there is a paucity of data on how these relate to the level of past use. Objectives: to assess the incidence of Ecstasy‐attributed problems as reported by novice, moderate and heavy users. Methods: 763 unpaid volunteers took part in a WWW study of recreational drug use. This report is based on the 282 Ecstasy users from that sample, who comprised 109 novice users (1–9 occasions), 136 moderate users (10–99 occasions), and 36 heavy users (+100 occasions). Yes/no responses were automatically recorded to a series of questions covering psychobiological problems experienced when drug‐free, which were attributed by the respondents to their Ecstasy use. Results: Depression, memory problems, anxiety, mood fluctuation, poor concentration, infections, tremors/twitches and weight loss, were all significantly associated with the extent of Ecstasy use. Thus memory problems attributed to Ecstasy were reported by 19% of novice users, 52% of heavy users and 73% of heavy users (chi‐square 42.74, df=2, p<0.001); many of the other variables showed similar trends. Conclusions The incidence of problems attributed to Ecstasy use, is directly related to the number of occasions it has been used. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 22 references indexed in Scilit:
- Differential effects of Ecstasy and cannabis on self‐reports of memory ability: a web‐based studyHuman Psychopharmacology: Clinical and Experimental, 2001
- Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical researchHuman Psychopharmacology: Clinical and Experimental, 2001
- Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approachHuman Psychopharmacology: Clinical and Experimental, 2001
- Subjective ratings of prospective memory deficits in MDMA (‘ecstasy’) usersHuman Psychopharmacology: Clinical and Experimental, 2001
- A comparison of the validity of two psychiatric screening questionnaires: the Arabic General Health Questionnaire (AGHQ) and Self-Reporting Questionnaire (SRQ-20) in UAE, using Receiver Operating Characteristic (ROC) analysisEuropean Psychiatry, 2001
- Psychobiological problems in heavy ‘ecstasy’ (MDMA) polydrug usersDrug and Alcohol Dependence, 2000
- Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)Journal of Neurology, Neurosurgery & Psychiatry, 2000
- (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical StudiesNeuropsychobiology, 2000
- Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficitsJournal of Psychopharmacology, 1998
- Mood and cognitive effects of ± 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week-end ‘high’ followed by mid-week lowAddiction, 1997